INTRODUCTION
Human peroxisomal multifunctional enzyme （MFE） type 1 （MFE1） , often called L -bifunctional protein （LBP） , and MFE2, often called 17-β-hydroxysteroid dehydrogenase type 4 （HSD17B4） or D-bifunctional protein （DBP） , catalyze the hydration of trans-2-enoyl-coenzyme A （CoA） and the subsequent dehydrogenation of 3-hydroxyacyl-CoA in peroxisomal fatty acid β-oxidation 1-3） . Although both MFE1 and MFE2 possess hydratase and dehydrogenase activities, their molecular structures differ 3） . It is known that MFE1 and MFE2 yield 3S-and 3R-hydroxyacyl-CoA from trans-2-enoyl-CoA, respectively （Fig. 1） ; however, the physiological significance of this distinction is not clear. Deficiency of MFE2 causes fatal lipid metabolism disorders 4-8） , whereas the consequences of MFE1 deficiency remain unclear. Thus, it is considered that MFE2 is very important for the maintenance of life. It is anticipated that more detail knowledge of the functions and mechanisms of MFE1 and MFE2 will aid not only in a greater understanding of lipid metabolisms, but also in the discovery of methods to cope with MFE2 deficiencies.
As a result, we developed a method to investigate the stereospecificities of MFE hydratase activity that incorporates high performance liquid chromatography （HPLC） and a chiral separation column to concurrently measure 3S-hydroxyhexadecanoyl-CoA （3S-OH-16-CoA） and 3R-hydroxyhexadecanoyl-CoA （3R-OH-16-CoA） . Using this method, we confirmed that rat liver MFE1 and MFE2 yield 3S-OH-16-CoA and 3R-OH-16-CoA, respectively, from trans-2-hexadecenoyl-CoA （16eno-CoA） 9, 10）
. Our results suggest that the method is practicable for discerning MFE1 and MFE2 hydratase activities when they coexist in the same preparation. To determine the usefulness of the developed method using completely purified hydratase, we cloned and expressed the hydratase domain of wild-type human MFE2 （MFE2Hwt） , and performed the hydratase assay. To facilitate purification and assaying, MFE2Hwt was expressed as a green fluorescent protein （GFP） tagged protein 11） . DBP deficiency is an autosomal recessive peroxisomal fatty acid oxidation disorder. Most patients with DBP deficiency suffer from hypotonia, seizures, and delayed development, and die, typically of pneumonia, within the first 2 years of life. Biochemically, very long chain fatty acids, α-methyl branched-chain fatty acids, and abnormal bile acid intermediates accumulate in the plasma of these patients. DBP deficiency is categorized into 3 types as follows: （i） type I is a deficiency of both the hydratase and the dehydrogenase units of DBP; （ii） type II is a deficiency of only the hydratase unit; and （iii） type III is a deficiency of only the dehydrogenase unit 12） . Multiple mutations in MFE2 have been reported 6） , 13-17） , some of which induce DBP deficiency. Ferdinandusse et al. sequenced the MFE2 domain of patients with DBP deficiency, and identified 12 cases of MFE2 hydratase （MFE2H） deficiency, classified as MFE2 deficiency type II 17） , all of which were caused by missense mutations. The effects of these mutations on the structural integrity of MFE2H were investigated by in silico protein structure analysis 17） . Missense mutations in type II DBP deficiency were categorized as follows （num-bering of amino acids starts at the first methionine） : L405P and G533R disrupt ligand interaction; P529L and H532R disrupt active site architecture; R506C, R506H, and I516T disrupt dimerization; N457Y disrupts domain folding; and the effects of A348T and N457D could not be determined 17） . On the other hand, Qin et al., using site-directed mutagenesis to investigate the importance of hydratase activity of 12 protic amino acids conserved among 9 eukaryotic species showed that E366 and D510 are required for hydratase activity 18） . The consequences of the other MFE2 missense mutations for hydratase activity are, however, still unclear. Accordingly, to scrutinize the effects of these mutations, we used site-directed mutagenesis to generate GFP fusion MFE2 variants corresponding to 17 missense mutations, including the abovementioned mutants, and measured their hydratase activities in order to validate our HPLC method, using results from previous reports.
EXPERIMENTAL

Materials and instruments
Human liver complementary DNA （cDNA） was purchased from Agilent Technologies （Santa Clara, CA） . DNA polymerase, restriction enzymes, and DNA ligase were purchased from Invitrogen （Carlsbad, CA） . Luria-Bertani （LB） medium was purchased from MP Biomedicals LLC. （Solon, Ohio, US） . Isopropylthio-β-D-galactoside （IPTG） was purchased from Wako Pure Chemicals Ind., Ltd. （Osaka, Japan） . Diethylaminoethyl （DEAE） Sephacel was purchased from GE Healthcare （Uppsala, Sweden） . 3R-OH-16-CoA, 3S-OH-16-CoA, and 16eno-CoA were synthesized chemically as described in previous reports 9, 10） . All other materials were of analytical grade, and distilled water was used throughout the study. Centrifugation was performed using an Eppendorf Centrifuge 5415R （Eppendorf Co., Ltd., Hamburg, Germany） and a KUBOTA 6930 centrifuge （Kubota Co., Tokyo, Japan） . DNA was sequenced using an ABI PRISM 310 genetic analyzer （Applied Biosystems, Foster City, California, US） . The fluorescence of GFP was confirmed visually using a CSL-6A ultraviolet （UV） lamp （Cosmo Bio Co., Ltd., Tokyo, Japan） and a 3UV transilluminator （UVP LLC, Upland, CA） . The fluorescence intensity of GFP was measured using an MTP-2000 microplate reader （Corona Electric Co., Ltd., Hitachinaka, Japan） in a 96-well white microplate （Nunc, Roskilde, Denmark） . HPLC was performed using a Shimadzu LC-10ADvp system equipped with an SPD-10vp UV detector （Shimadzu Co., Kyoto, Japan） , and a CHIRALPAK AD-RH separation column （4.6×150 mm, 5 μm, Daicel Chemical Ind. Ltd., Tokyo, Japan） .
Construction of plasmid
MFE2Hwt was amplified by standard polymerase chain reaction （PCR） with the following primers: forward primer; 5' -TTTCTGCAGTCAGGATTTGCTGGAGC-3' , Pst I site is underlined and reverse primer, 5' -TTTAAGCTTTCATTA-CAGCTTCCCGCCC-3' , Hind III site is double-underlined, using human liver cDNA as a template. After digestion of the PCR product by Pst I and Hind III, this fragment was cloned into a similarly digested pGFP-Staphylococcus protein A domain B （SpAB ）
19）
, and the resulting plasmid was named pGFP-MFE2Hwt （Fig. 2） . To construct the GFP-MFE2H variants, amino acid mutations were introduced into pGFP-MFE2Hwt by site-directed mutagenesis 20） with specific primers （Table 1） .
Expression and puri cation
Competent Escherichia coli （E. coli） JM109 cells were treated with 50 mM calcium chloride 21） and transformed with pGFP-MFE2Hwt. The cells were precultured in 10 mL of LB broth overnight at 37℃, after which 100 mL of LB broth was supplemented with 1 mL of the preculture medium and shaken at 37℃ until the logarithmic growth phase. Then, the medium was supplemented with 500 μL of 100 mM IPTG and shaken further for 20 h at 25℃. The cells were collected by centrifugation （12,000 rpm, for 10 min） and washed with 10 mL of 10 mM phosphate buffer （pH 7.6） . The cells were disrupted by sonicoscillation in 1 mL of the same buffer; further, 1 mL sonicate was applied to 200 μL of diethylaminoethyl （DEAE） -Sephacel column equilibrated with 10 mM phosphate buffer （pH 7.6） , and GFP-MFE2Hwt was adsorbed onto the resin. After washing with 10 mL of 10 mM phosphate buffer （pH 7.6） and 1 mL of 10 mM phosphate buffer （pH 7.6） containing sodium chloride （50 mM final） , the eluate （1 mL of 10 mM phosphate buffer ［pH 7.6］ containing sodium chloride ［100 mM final concentration］ ） was collected. This fraction was stored at -80℃ until further use. For further purification of GFP-MFE2Hwt, the eluate was migrated by native polyacrylamide gel electrophoresis （PAGE） using a cylindrical polyacrylamide gel （12×90 mm） . The polyacrylamide concentrations of stacking and separation gels were 6% and 12%, respectively. Electrophoresis was carried out at a constant voltage of 150 V with Tris-glycine buffer （25 mM Tris, 192 mM glycine, pH 7.6） . The green-fluorescent band was spliced out while monitoring with a UV transilluminator （excitation at 365 nm） and extracted from the slice electrophoretically into Tris-glycine buffer in a dialysis tube. The purity of GFP-MFE2Hwt was confirmed by native-PAGE and sodium dodecyl sulfate （SDS） PAGE. The protein concentration was determined by Lowry method 22） . GFP-MFE2H variants were expressed the same as for GFPMFE2Hwt, and purified using DEAE-Sephacel.
Incubation and HPLC
Initially, to establish optimal conditions for the assay, we examined the correlation between the fluorescence intensity of GFP-MFE2Hwt and formation of 3R-OH-16-CoA. The fluorescence intensities of GFP-MFE2Hwt and its variants were adjusted in the linear range with 10 mM phosphate buffer （pH 7.6） . During measurement of fluorescence intensity, the settings of the MTP-2000 microplate reader were as follows: excitation, 400 nm; emission, 530 nm; sense, ×10; and response, 5.
Forty microliters of 100 μM 16eno-CoA was added to 10 μL of enzyme solution. After 10 min of incubation at 30℃, the reaction mixture was supplemented with 10 μL of 0.1 M HCl on ice to stop the reaction. Then 20 μL of the mixture was injected onto an HPLC column. HPLC was performed according to the method described in a previous report 10） with the following conditions: chiral separation MFE2Hwt was amplified by PCR using human liver cDNA as a template. The PCR product was replaced with Pst I-Hind III fragment of pGFP-SpAB and the resultant was named pGFP-MFE2Hwt. E. coli JM109 was transformed with the plasmid and GFP-MFE2Hwt was expressed in the cells. The numbering of amino acids starts at the first methionine.
column, CHILRALPAK AD-RH （4.6×150 mm, 5 μm） ; mobile phase, 10 mM phosphate buffer （pH 5.0） /methanol （35/65） ; flow rate, 0.5 mL/min; column temperature, 25℃; and CoA esters monitoring, at 260 nm. 3R-OH-16-CoA was quantified by an absolute calibration method. In this study, 1 unit of GFP-MFE2Hwt and its variants was defined as a fluorescence intensity value of 1.
RESULTS AND DISCUSSION
GFP-MFE2Hwt
Neither 3R-OH-16-CoA （product） nor 16eno-CoA （sub-strate） were detected by HPLC in the incubation mixture of 16eno-CoA and sonicate solution of E. coli expressing GFP-MFE2Hwt suggesting that the E. coli contains factors that degrade the CoA esters 23） and that further purification of GFP-MFE2Hwt was necessary. The sonicate solution was therefore applied to the DEAE-Sephacel to remove the contaminant. The DEAE-Sephacel fraction of GFP-MFE2Hwt yielded 3R-OH-16CoA, whereas that of the control GFP-SpAB did not generate any product data not shown . To confirm the origin of the R-specific hydratase activity, the fraction was further purified using cylindrical native-PAGE. The purity of GFP-MFE2Hwt was confirmed with standard native-PAGE while monitoring the fluorescence of GFP, and a Coomassie Brilliant Blue CBB staining was performed. Purified GFP-MFE2Hwt was observed as a single band Fig. 3 . In addition, GFP-MFE2Hwt extracted from this band yielded 3R-OH-16-CoA from 16eno-CoA, whereas a control GFP-SpAB did not yielded this product Fig. 4 . These results confirmed that the R-specific hydratase activity was attribute to GFP-MFE2Hwt. Fusion of MFE2H with GFP not only facilitated purification but it was also easy to assay because of its traceability with a UV lamp or a fluorescence microplate reader. As a result, 7.65 μg of GFP-MFE2Hwt was obtained from 0.5 g wet weight of the cells. The GFP-MFE2Hwt stock solution was 15.3 μg/mL, and the fluorescence intensity of GFP-MFE2Hwt correlated with its concentration within 1-15 g/mL r 0.998, Fig.  5A . The formation of 3R-OH-16-CoA was a liner function of the amount of GFP-MFE2Hwt slopes 0.02 and 0.04 were observed within the 0-15 unit and 15-40 unit ranges, respectively, and the ratio of formation of 3R-OH-16-CoA was approximately constant at over 40 units Fig. 5B . As anticipated, GFP-MFE2Hwt showed R-specific hydratase activity. These results suggested that the GFP fusion did not interfere with the functions of the MFE2H domains.
Hydratase activities of variants
The hydratase activities of the GFP-MFE2H variants are shown in Table 2 . Hydratase activity was abolished by the missense mutations E366G, L405P, R506C, R506H, D510Y, P529L, H532R, and G533R, suggesting that these mutations, which have been identified by Ferdinandusse et al., The fractions obtained from each purification step were migrated by native-PAGE. GFP-SpAb and GFP-MFE2Hwt were detected by UVirradiation (A), and the purification grade was confirmed by CBB staining (B). Each number indicates the following: lanes 1 and 4, sonication solution; lanes 2 and 5, DEAE-Sephacel; lanes 3 and 6, native-PAGE. . Consistent with their analysis, hydratase activity was reduced to less than 10% of wild type by N457Y, N457D, and I516. Although it is considered that N457Y disrupts domain folding, the effect of N457D is not clear. Moreover, it has been reported that the symptoms of DBP deficiency in patients with the N457D are milder than in patients with the N457Y mutation 17） . Hydratase activity was, however, scarcely detectable for both N457Y and N457D variants suggesting that both mutations may cause serious DBP deficiency. I516T has been identified in DBP deficiency patients heterozygous for N457Y or N457D 17） . Moreover, Qin et al. reported that the hydrophobicity of isoleucine is important for dimerization and for the active site conformation of the hydratase unit 18） . Our results suggest that the I516T mutation, per se, is sufficient to cause type II DBP deficiency. Hydratase activity was largely unaffected by the A348T, A427V, A491T, W511R, I559V, and A606S mutations, although some increase or decrease in activity was observed. It has been suggested that these mutations have a minor effect on fatty acid metabolism 17） . Ferdinandusse et al. have predicted that A348T, in particular, indirectly affects the structure of domains required for dimerization. A348T has, however, been found in a patient with DBP deficiency with heterozygous deletion of the exon 4 encoding the dehydrogenase domain of MFE2 17） . Therefore, in this case, it was that DBP deficiency was caused not by A348T but by deletion of exon 4.
3.3 HPLC analysis for diagnosis of bifunctional protein de ciencies Previously, patients with DBP deficiency were misdiagnosed with LBP deficiency because of the absence of methods for direct discrimination between DBP and LBP deficiency 14） . The chiral separation/HPLC analysis method described in this article, enables more precise discrimination of cases of deficiency of DBP or LBP. According to the Online Mendelian Inheritance In Man （OMIM） resource, diseases resulting from LBP deficiency have not been characterized thus far. If LBP deficiency persists in the future, our HPLC method will contribute to its detection because it specifically detects not only 3R-hydroxyacyl-CoA but also 3S-hydroxyacyl-CoA.
